Aurora kinase A (AURKA) is a therapeutic target in NE‐transformed tumors, as its inhibition both degrades the oncogenic driver N‐Myc [301] and is synthetically lethal with RB tumor suppressor loss [302]. The gene discussed is RB1; the disease is neoplasm.